Diabetes Self-Management, Education, and Support
|
2016 ADA Guideline Recommendations |
|
Types of Diabetes Mellitus |
|---|
|
2016 ADA Standard of Medical Care Guideline Recommendations |
|
Cardiovascular Disease and Risk Management |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivani Chaparala M.B.B.S [2]; Tarek Nafee, M.D. [3]
See also Diabetes mellitus type 2 Patient education
Diabetic control is especially difficult without continuity of care[1].
Pharmacist-led interventions can improve glycemic control in patients with diabetes, particularly individual education in those with a baseline HbA1c greater than 8%[2][3]. Pharmacist-led interventions that include patient goal-setting, medication reviews, pharmacist feedback to the physician, addressing patient health beliefs, and medication knowledge improves patient medication adherence and reduces the number of hospitalizations in this patient population[2][4].
2016 ADA Standards of Medical Care in Diabetes Guidelines[5]
| "1.In accordance with the national standards for diabetes self-management education (DSME) and support (DSMS), all people with diabetes should participate in DSME to facilitate the knowledge, skills, and ability necessary for diabetes self-care and in DSMS to assist with implementing and sustaining skills and behaviors needed for ongoing self-management, both at diagnosis and as needed thereafter (Level of Evidence: B)" |
| "2.Effective self-management, improved clinical outcomes, health status, and quality of life are key outcomes of DSME and DSMS and should be measured and monitored as part of care (Level of Evidence: C)" |
| "3.DSME and DSMS should be patient centered, respectful, and responsive to individual patient preferences, needs, and values, which should guide clinical decisions (Level of Evidence: A)" |
| "4. DSME and DSMS programs should have the necessary elements in their curricula that are needed to prevent the onset of diabetes. DSME and DSMS programs should therefore tailor their content specifically when prevention of diabete is the desired goal (Level of Evidence: B)" |
| "5. Because DSME and DSMS can result in cost savings and improved outcomes (Level of Evidence: B), DSME and DSMS should be adequately reimbursed by third-party payers (Level of Evidence: E)" |
References
- ↑ Younge R, Jani B, Rosenthal D, Lin SX (2012). "Does continuity of care have an effect on diabetes quality measures in a teaching practice in an urban underserved community?". J Health Care Poor Underserved. 23 (4): 1558–65. doi:10.1353/hpu.2012.0193. PMID 23698670.
- ↑ 2.0 2.1 Deters MA, Laven A, Castejon A, Doucette WR, Ev LS, Krass I; et al. (2017). "Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components". Ann Pharmacother: 1060028017733272. doi:10.1177/1060028017733272. PMID 28948839.
- ↑ Duke SA, Colagiuri S, Colagiuri R (2009). "Individual patient education for people with type 2 diabetes mellitus". Cochrane Database Syst Rev (1): CD005268. doi:10.1002/14651858.CD005268.pub2. PMID 19160249.
- ↑ Erku DA, Ayele AA, Mekuria AB, Belachew SA, Hailemeskel B, Tegegn HG (2017). "The impact of pharmacist-led medication therapy management on medication adherence in patients with type 2 diabetes mellitus: a randomized controlled study". Pharm Pract (Granada). 15 (3): 1026. doi:10.18549/PharmPract.2017.03.1026. PMC 5597801. PMID 28943985.
- ↑ "care.diabetesjournals.org" (PDF).